πŸ—‚οΈ Navigation

Insilico Medicine Pharma.AI

End-to-end AI-driven drug discovery and development.

Visit Website β†’

Overview

Insilico Medicine is a clinical-stage biotech company that has developed Pharma.AI, an end-to-end AI-driven platform. It utilizes generative AI and deep learning for target discovery (PandaOmics), de novo small molecule design (Chemistry42), and predicting clinical trial outcomes (InClinico). The company has a pipeline of therapeutic programs developed using its platform.

✨ Key Features

  • AI-driven Target Discovery (PandaOmics)
  • Generative Chemistry for Small Molecule Design (Chemistry42)
  • Clinical Trial Outcome Prediction (InClinico)
  • Biomarker Discovery
  • Aging Research

🎯 Key Differentiators

  • End-to-end integrated platform from target discovery to clinical trials.
  • Strong focus on generative AI for novel molecule creation.
  • Proven ability to bring AI-designed drugs to clinical trials.

Unique Value: Significantly reduces the time and cost of drug discovery and development through a comprehensive, AI-driven approach.

🎯 Use Cases (5)

Novel target identification De novo drug design Biomarker development Predicting clinical trial success Drug repurposing

βœ… Best For

  • Advanced the first generative AI-discovered and designed drug to human clinical trials.
  • Developed a pipeline of over 30 therapeutic programs.

πŸ’‘ Check With Vendor

Verify these considerations match your specific requirements:

  • Organizations looking for a simple, off-the-shelf molecular modeling tool without AI capabilities.

πŸ† Alternatives

Recursion Pharmaceuticals Exscientia BenevolentAI

Offers a more holistic and integrated AI platform compared to companies that focus on specific stages of drug discovery.

πŸ’» Platforms

Web API

πŸ”Œ Integrations

NVIDIA BioNeMo

πŸ›Ÿ Support Options

  • βœ“ Email Support
  • βœ“ Dedicated Support (Enterprise tier)

πŸ”’ Compliance & Security

βœ“ GDPR βœ“ SSO

πŸ’° Pricing

Contact for pricing

Free tier: NA

Visit Insilico Medicine Pharma.AI Website β†’